IDEX Corporation research snapshot
IEX AI stock analysis currently reads IDEX Corporation as a high-quality industrial compounder with specialized engineered products, strong cash conversion, disciplined portfolio management, and improving 2026 guidance. At the July 8, 2026 data cutoff, IEX traded near $221.07 with a verified market capitalization near $16.36 billion. The IEX AI stock forecast uses scenario ranges rather than a fixed price prediction because organic growth, Health & Science Technologies momentum, acquisition integration, orders, margins, rates, and the market multiple can change the outcome.
Current price
$221.07 close on July 7, 2026
Market cap
$16.36 billion verified market cap
AI score
72 / 100
Rating
High-quality engineered products compounder with specialty-market exposure, acquisition execution risk, and a valuation that already prices in steady growth
Trend status
Above the 50-day and 200-day moving averages with neutral momentum after a strong 52-week advance
Data cutoff (updated weekly)
July 8, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | IDEX sells mission-critical precision components, pumps, fluidics, sealing, fire and safety products, and dispensing systems into specialized markets. The business has attractive cash conversion and niche-market economics. | High |
| Moat | The moat comes from application know-how, customer qualification, brand portfolios, installed bases, specialized engineering, distribution reach, and scale in selected niches rather than a broad network effect. | Medium-high |
| Management | CEO Eric D. Ashleman has emphasized 8020 focus, portfolio pruning, platform growth, acquisitions, and cash returns. The key test is whether capital allocation keeps compounding without overpaying for growth. | Medium-high |
| Financial trend | FY2025 sales were $3.458 billion and net income was $483.2 million. Q1 2026 sales rose 9% to $886.9 million, organic sales rose 5%, and management lifted 2026 adjusted EPS guidance to $8.35 to $8.55. | High |
| Valuation | At $221.07, the financial-rigor tool calculates about 32.70x TTM EPS, 4.06x book value, 26.76x free cash flow per share, and a 1.28% dividend yield. The valuation requires durable growth and margin discipline. | High |
| Technical trend | StockAnalysis showed IEX above its 50-day moving average near $216.20 and 200-day moving average near $192.19, with RSI near 50.87 and 20-day average volume near 717,620 shares. | Medium |
| Risk level | Main risks include premium valuation, industrial cycle exposure, slower FMT or FSDP volumes, acquisition integration, tariffs, price-cost pressure, customer project timing, and a more expensive capital market backdrop. | Medium |
| AI confidence | Descriptive confidence is high because company releases, SEC filings, StockAnalysis, Macrotrends, and market data agree on the core numbers. Return confidence is lower because a premium multiple leaves less room for execution misses. | High data confidence |
| Investment certainty | IEX may fit quality-growth watchlists, but stronger certainty needs either a better entry price or evidence that higher 2026 organic growth, HST demand, and M&A returns can support the current multiple. | Medium |
IEX AI stock forecast
The IEX AI stock forecast is scenario-based because the stock depends on organic orders, HST growth platforms, margin mix, acquisitions, industrial demand, free cash flow, and the valuation multiple. Using a $221.07 price reference, a $8.45 FY2026 adjusted EPS midpoint, and a three-year model checked with the financial rigor tool, the mechanical outcomes are about $319 in a bullish case, $238 in a base case, and $139 in a bearish case before dividends.
$310 to $325 before dividends
More likely if 2026 organic sales growth stays above management guidance, HST orders tied to data center, semiconductor, space, defense, and life sciences demand remain firm, acquisitions add quality growth, and investors keep IEX near a 30x forward multiple.
$230 to $245 before dividends
More likely if adjusted EPS compounds around a mid-single-digit pace from the 2026 midpoint, FMT and FSDP stay mixed but stable, free cash flow remains strong, and the market values IEX near 25x earnings.
$135 to $145 before dividends
More likely if industrial demand softens, order growth fades, acquisitions dilute returns, tariff or price-cost pressure hits margins, and the earnings multiple compresses toward the high teens.
IEX AI technical analysis
IEX AI technical analysis is constructive but not early as of the July 8, 2026 data cutoff. StockTitan showed a July 7 close near $221.07. StockAnalysis listed a 50-day moving average near $216.20, a 200-day moving average near $192.19, RSI near 50.87, 20-day average volume near 717,620 shares, and a 52-week price gain near 21.97%.
| Level | Value | Why it matters |
|---|---|---|
| Current price reference | $221.07 close | StockTitan showed IEX at $221.07 at the July 7, 2026 close. |
| Immediate support | $216 to $218 | This area brackets the 50-day moving average and the first zone where a pullback would test short-term trend support. |
| Trend support | $205 to $210 | A pullback into this zone would test whether buyers still treat IEX as a quality industrial compounder rather than a fully priced stock. |
| Deeper support | $190 to $193 | This zone sits near the 200-day moving average. A sustained break would weaken the medium-term technical picture. |
| Near resistance | $225 to $230 | This range is the first area to watch after the recent close and should be confirmed by volume and orders commentary. |
| Upper resistance | $238 to $245 | This band overlaps the base-case scenario output and the area where valuation discipline becomes more important. |
| Moving averages | 50-day near $216.20, 200-day near $192.19 | Price is above both averages, so the trend is positive, but the distance above the 200-day average means entry timing matters. |
| Momentum | RSI near 50.87 | Momentum is neutral rather than overbought. A breakout needs price confirmation above resistance and improving volume. |
| Volume | 20-day average near 717,620 shares | Volume should be watched around Q2 results, guidance changes, acquisition updates, and order commentary. |
| Invalidation | Close below $216, then below $190 | A close below the 50-day average would reduce short-term confidence. A break below the 200-day average would challenge the medium-term trend. |
IEX AI trading strategy
The IEX AI trading strategy below is a rules-based research framework, not personal advice. It connects price levels with organic sales, orders, HST demand, margin mix, free cash flow, acquisition returns, tariffs, and valuation discipline.
Watch for IEX to hold the $216 to $218 area and then reclaim $225 to $230 with improving volume, stable or raised 2026 guidance, and continued HST order strength.
A failed breakout followed by a close below the 50-day moving average should reduce trend confidence, especially if orders or margin commentary weaken.
If IEX pulls back toward $205 to $210 without an earnings reset, compare the lower price with the $8.35 to $8.55 adjusted EPS guide, free cash flow conversion, order growth, and acquisition pipeline.
Do not treat quality as enough protection if the multiple remains high while organic growth slows or price-cost pressure worsens.
Track organic orders, HST revenue growth, FMT and FSDP volume trends, adjusted EBITDA margin, free cash flow, net debt, share repurchases, dividend growth, tariffs, and M&A integration updates.
Position sizing should reflect that a strong business can still produce weak stock returns if purchased at too high a multiple.
Investment research summary
Customers pay IDEX for specialized components and systems that solve mission-critical fluidics, sealing, pumping, safety, dispensing, and precision engineering problems. The value proposition is reliability in applications where downtime, contamination, failure, or inaccurate flow control can be costly.
IDEX benefits from engineering know-how, customer qualification, niche leadership, installed products, distribution, brand portfolios, and an 8020 operating model. The moat is strong in selected applications but must be renewed through product innovation and disciplined acquisitions.
The thesis fails if investors overpay for a quality story, HST demand fades, FMT and FSDP remain weak, acquisitions destroy value, tariffs or price-cost pressure reduce margins, or industrial customers delay projects.
Eric D. Ashleman and the leadership team frame IDEX around focused growth platforms, 8020 simplification, portfolio upgrades, M&A, dividends, and buybacks. Capital allocation quality is central because acquired growth is part of the compounding model.
Life sciences, semiconductor, data center power, space, defense, water, energy, and industrial automation can support long-term demand. The offset is that many end markets remain cyclical and project-driven.
IEX has quality characteristics, but the current price implies high confidence in continued growth. Margin of safety is limited unless earnings compound, free cash flow conversion stays high, and the market keeps a premium industrial multiple.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Current price | $221.07 close on July 7, 2026 | StockTitan IEX Overview | July 8, 2026 |
| Market capitalization | $16.36 billion verified from $221.07 price and 74.0 million shares | StockTitan IEX Overview and financial-rigor market-cap check | July 8, 2026 |
| Shares outstanding | 74.0 million current shares, cross-checked with Macrotrends 0.074 billion March 2026 share count | StockTitan and Macrotrends IDEX Shares Outstanding | July 8, 2026 |
| FY2025 revenue | $3.458 billion, cross-checked against Macrotrends and StockAnalysis | IDEX FY2025 Results | July 8, 2026 |
| FY2025 net income | $483.2 million, matched by SEC 10-K, StockAnalysis, and AlphaQuery | IDEX FY2025 Form 10-K | July 8, 2026 |
| Q1 2026 sales and earnings | $886.9 million sales, up 9%; reported diluted EPS $1.61; adjusted diluted EPS $2.00 | IDEX Q1 2026 Results | July 8, 2026 |
| FY2026 guidance | Organic sales growth 3% to 4%; adjusted diluted EPS $8.35 to $8.55 | IDEX Q1 2026 Results | July 8, 2026 |
| Cash and debt | $586.2 million cash and $1.90 billion total debt on StockAnalysis; FY2025 10-K cash was $580.0 million | StockAnalysis IEX Statistics and SEC FY2025 Form 10-K | July 8, 2026 |
| Valuation metrics | 32.70x TTM EPS, 4.06x book value, 26.76x FCF per share, 1.28% dividend yield | StockAnalysis IEX Statistics and financial-rigor valuation check | July 8, 2026 |
| Technical reference data | 50-day moving average $216.20, 200-day moving average $192.19, RSI 50.87, 20-day average volume 717,620 | StockAnalysis IEX Statistics | July 8, 2026 |
| Business segments | HST, FMT, and FSDP are the three reportable segments | IDEX FY2025 Form 10-K | July 8, 2026 |
This IEX AI stock analysis is an informational research tool, not investment advice, a recommendation, or a promise of future performance. Forecast scenarios are based on available data as of July 8, 2026 and may be wrong if orders, margins, acquisitions, industrial demand, rates, valuation multiples, or market conditions change.
